PATENT CLAIM ANALYSIS

Application Number: 16011050
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "557000"]

Abstract:
Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Claim (Index 4):
The method of  claim 3 , wherein the immune disorder is an allergic symptom or HIV retrovirus infection.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 94.0
- Lexical Diversity: 1.83333
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15724002', '15039964', '15576350', '15710249', '11253812']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7837121487834593
- 35 USC 102 Novelty (BERT): 0.5749336064369029
- Combined Prediction Score: 0.7628342945488037
- Mean Citation Score: 442.875134
- Max Citation Score: 570.521
- Similarity Product: 333.65578216075903

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test